Scythian Biosciences
Business Services · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
639 5th Ave SW Ste 1250, Calgary, Albert...Phone Number
(212) 729-9208Website
www.scythianbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Scythian Biosciences
Scythian Bio is a company that is currently in the process of developing its online presence. While specific products and services are not yet available, the company is preparing to offer innovative solutions in the biotechnology sector. The intended clients are likely to include healthcare providers and researchers looking for advanced biotechnological applications. Further details will be revealed once the website is launched.Explore more
Scythian Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scythian Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Scythian Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Scythian Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Scythian Biosciences is spiking on competitors!
Product Launch: Get notified when Scythian Biosciences launches new products
Congratulate Masked Content for being promoted to Masked Content at Scythian Biosciences
Click to see if Scythian Biosciences had a recent Job posting/layoffs
Earning: See what the market has to say on Scythian Biosciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Scythian Biosciences has new funding data
Recommended Actions
Find VP level buyers at Scythian Biosciences
Find 3 more new buyers
Compare Similar Companies to Scythian Biosciences
Compare insights from companies similar to Scythian Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Scythian Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Scythian Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Scythian Biosciences.
Scythian Biosciences Tech Stack
A closer look at the technologies used by Scythian Biosciences
See more technologies
Scythian Biosciences News & Media
SOL Global Fiscal 2021 Net Income Increases 62% To 127.33M, Divests Cannabis Assets
SOL Global Investments Corp. (OTCPK:SOLCF) (CSE:SOL) (Frankfurt:9SB) reported fourth-quarter financial results and audited financial results for the year ended November 30, 2021. Audited Year-End Results read moreSOL Global FY2021 Net Income Improves 62% To $127.33M, Divests Cannabis Assets
SOL Global Investments Corp. (OTCPK:SOLCF) (CSE:SOL) (Frankfurt:9SB) reported fourth quarter financial results and audited financial results for the year ended November 30, 2021. Audited Year-End Results read moreSOL Global Reduces Credit Facility From $50 To $30M, Announces Director Resignation
SOL Global Investments Corp. (CSE:SOL) (OTCQ:SOLCF) (Frankfurt:9SB) announce that it has repaid an additional $2.5 million toward its $50 million credit facility with an arm's length lender, reducing the principal amount of the credit facility to $30 million. read moreSOL Global Wraps Up $30M Oversubscribed Substantial Issuer Bid And Takes Up Shares
SOL Global Investments Corp. (CSE: SOL) (OTCQ: SOLCF) (Frankfurt:9SB) revealed that recently it has taken up and purchased for cancellation a total of 7.4 million common shares at $4.05 per share pursuant to its substantial issuer bid which expired on Nov. 26, 2021, for an aggregate purchase price of $30 million. read more
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scythian Biosciences
Sign Up For FreeTo access detailed company insights
Scythian Bio is a company that is currently in the process of developing its online presence. While specific products and services are not yet available, the company is preparing to offer innovative solutions in the biotechnology sector. The intended clients are likely to include healthcare providers and researchers looking for advanced biotechnolo... Read More
